Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Not according to the PR from two weeks ago:

http://www.ipharminc.com/press-release/2019/3...is-program

For the Phase 3 program, the Company anticipates international clinical trial enrollment, with participating sites located in the U.S. and in Europe. EMA advice is integral to this plan by helping to ensure that the program meets European standards.

The company plans to do an international phase 3 in order to kill both the FDA and EMA requirements for approval with one stone. They likely had/have some guidance from a potential partner on this. A very good move by Leo if you ask me.